Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Composition of Patient Radiation Dose in Woven EndoBridge Embolization: Comparison with Stent-assisted Coiling].

Created on 15 Oct 2026

Authors

Daiki Horita, Takayuki Nomura, Hiroaki Neki, Satoshi Goshima

Published in

Nihon Hoshasen Gijutsu Gakkai zasshi. Volume 82. Issue 11.

Abstract

The aim of this study was to clarify the composition of patient radiation dose in Woven EndoBridge embolization (WEB) and to compare it with stent-assisted coiling (SAC).
Fifteen patients in the WEB group and 15 patients in the SAC group were retrospectively analyzed. Total air kerma at the reference point (Ka,r), fluoroscopy air kerma (Fl-Ka,r), stationary air kerma (St-Ka,r), rotational air kerma (Ro-Ka,r), air kerma-area product (PKA), fluoroscopy time, number of acquisitions, procedure time, and peak skin dose (PSD) were compared between the two groups.
Fl-Ka,r, fluoroscopy time, procedure time, and PSD were significantly lower in the WEB group than in the SAC group. In contrast, Ro-Ka,r was higher in the WEB group. The proportion of Ro-Ka,r to Ka,r was 46% in the WEB group and 26% in the SAC group.
Compared with SAC, WEB was associated with lower Fl-Ka,r and shorter procedure time, whereas the contribution of Ro-Ka,r was greater. Therefore, radiation dose management in WEB should not rely solely on Ka,r; rather, it is important to understand each dose component individually.

PMID:
42875225
Bibliographic data and abstract were imported from PubMed on 15 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement